Results 201 to 210 of about 330,161 (260)

Bridging bench to bedside: a dual-use framework for chromene-based anti-obesity and antiviral therapeutics. [PDF]

Front Pharmacol
Chávez-Jiménez SK, Solórzano-Mata CJ, Ávila-Curiel BX, Jarquín González EE, Zenteno E, Cabrera-Fuentes HA.   +5 more
europepmc   +1 more source

Sodium‐glucose cotransporter 2 inhibitors and the risk of late onset epilepsy: A real‐world cohort study

Epilepsia, EarlyView.
Abstract Objective Late onset epilepsy (LOE) is associated with substantial morbidity. Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) may exert neuroprotective effects. This study evaluated the association between SGLT2i and risk of LOE among older adults with type 2 diabetes mellitus.
Bing‐Hua Lin, Hui‐Min Huang, Hui‐An Lin, Sheng‐Feng Lin   +3 more
wiley   +1 more source

Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs. [PDF]

Curr Obes Rep
Villarroya F, Peyrou M, Giralt M.
europepmc   +1 more source

A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways. [PDF]

Front Endocrinol (Lausanne)
Park C, Kim Y, Raygani S, Grunvald E.
europepmc   +1 more source

Subjective Olfactory Impairment in a Patient Undergoing Anti-Obesity Pharmacotherapy: A Case of Symptom-Test Discrepancy. [PDF]

Life (Basel)
Lee HJ, Min HJ.
europepmc   +1 more source

Role of curcumin in altering gut microbiota for anti-obesity and anti-hyperlipidemic effects. [PDF]

Front Microbiol
Feng J.
europepmc   +1 more source

Clinical studies on anti-obesity medications in Arab countries. [PDF]

Saudi Med J
AlOtaibi HF, Al Taib HN, AlMuhaidib S, Alshagrawi S, Almufarrih A, Alalmai O, Alnaserallah S, Alodah N, Alqahtani SA, Alhazzani W.   +9 more
europepmc   +1 more source

Saudi Healthcare Providers' Perspectives and Clinical Practice of Anti-Obesity Medications: A National Survey. [PDF]

Saudi J Med Med Sci
AlOtaibi HF, Alnasrallah S, Alfadda AA, Alquassayer SA, Arafat AA, AlMuhaidib S, Alsayer RM, Alqahtani SA, Alhazzani W.   +8 more
europepmc   +1 more source